Breast Cancer Subtypes and Response to Docetaxel in Node-Positive Breast Cancer: Use of an Immunohistochemical Definition in the BCIRG 001 Trial

PURPOSE: To investigate the prognostic and predictive significance of subtyping node-positive early breast cancer by immunohistochemistry in a clinical trial of a docetaxel-containing regimen. METHODS: Pathologic data from a central laboratory were available for 1,350 patients (91%) from the BCIRG 0...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Hugh, Judith, Hanson, John, Cheang, Maggie Chon U., Nielsen, Torsten O., Perou, Charles M., Dumontet, Charles, Reed, John, Krajewska, Maryla, Treilleux, Isabelle, Rupin, Matthieu, Magherini, Emmanuelle, Mackey, John, Martin, Miguel, Vogel, Charles
Formato: Artigo
Idioma:English
Publicado em: American Society of Clinical Oncology 2009
Assuntos:
Original Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2667821/
https://ncbi.nlm.nih.gov/pubmed/19204205
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2008.18.1024
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
Seja o primeiro a partilhar um comentário!
Você deve entrar na sua conta antes

Registos relacionados